| Name | 4-(4,5-Dihydro-1H-imidazol-2-yl)benzonitrile |
|---|---|
| Synonyms |
MFCD16877945
4-(4,5-Dihydro-1H-imidazol-2-yl)benzonitrile Benzonitrile, 4-(4,5-dihydro-1H-imidazol-2-yl)- |
| Description | SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule inhibitor of SARS-CoV-2 that targets the main protease (Mpro) of the coronavirus. SARS-CoV-2-IN-59 has a strong interaction with residues on Mpro (Met 165, Gln 166, Met 165, His 41, Gln 189)[1]. |
|---|---|
| Related Catalog | |
| Target |
SARS-CoV-2[1] |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 327.7±44.0 °C at 760 mmHg |
| Molecular Formula | C10H9N3 |
| Molecular Weight | 171.20 |
| Flash Point | 152.0±28.4 °C |
| Exact Mass | 171.079651 |
| LogP | 0.00 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.642 |